Revolutionary EXOMIND TMS Offers New Hope for Depression and Mental Health

Precision Psychiatry's New EXOMIND TMS Treatment

West Des Moines, Iowa – September 16, 2025 – In a significant development for mental health treatment, Precision Psychiatry has begun offering EXOMIND TMS, a cutting-edge therapy designed to help individuals struggling with depression, anxiety, and mental fog. This innovative treatment stands out due to its noninvasive approach and its FDA clearance, paving the way for those who have not responded well to conventional medications.

According to Dr. Janice Landy, the medical director at Precision Psychiatry, the struggle against anxiety and depression affects numerous individuals daily. Drawing on her extensive 30 years of experience as a board-certified psychiatrist, she passionately emphasizes the importance of making mental health remedies more accessible and patient-friendly.

EXOMIND TMS operates through a simple yet advanced mechanism: a small applicator is positioned on the patient's head, delivering magnetic pulses to stimulate or suppress brain activity. Typically, each treatment session lasts around thirty minutes or less, making it easy for patients to incorporate into their busy schedules.

Research has consistently demonstrated the efficacy of TMS in alleviating symptoms associated with various mental health conditions, such as depression, anxiety, and obsessive-compulsive disorder (OCD). Dr. Landy notes that global research efforts are currently underway to expand the use of TMS technology for other disorders as well, highlighting its versatility and potential.

Beyond treating severe mental health concerns, EXOMIND has proven highly effective in bolstering general mental wellness. To achieve optimal results, patients are advised to undergo treatment twice a week for three weeks. Those who have opted for this therapy frequently report a plethora of benefits, including enhanced clarity, reduced irritability, improved cognitive function, and a greater sense of self-control.

One of the noteworthy aspects of the EXOMIND treatment is its ability to influence physical wellness as well. Research indicates that individuals receiving six treatments experienced a decrease in cravings for certain foods, leading to an average weight loss of four to five pounds. This dual impact on both mental and physical health positions EXOMIND as a holistic treatment option.

The dedicated multidisciplinary team at Precision Psychiatry is committed to providing the highest quality of care by employing a range of evidence-based interventions that consider the various factors influencing mental health. They emphasize the necessity of treating patients as partners in their care journey, ensuring they feel heard, supported, and empowered throughout the process.

In an effort to familiarize the community with the EXOMIND technology, Precision Psychiatry is hosting a complimentary open house on October 15th from 11:30 AM to 2:30 PM at their facility located at 1701 48th Street, Suite 110, West Des Moines, IA 50266. The event will include a brief presentation at noon, where attendees can learn more about the treatment while enjoying refreshments and demonstrations. Special pricing will also be available for participants. Individuals interested in this unique opportunity can RSVP by calling 515-514-1186. For additional information, visit www.precisionpsychiowa.com.

EXOMIND TMS marks a transformative step in the quest for effective mental health treatments, blending advanced technology with compassionate care to redefine patient experiences.